Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients.
about
Methylated circulating tumor DNA in blood: power in cancer prognosis and responseCirculating DNA as biomarker in breast cancerMethylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis.Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients.Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.Circulating nucleic acids as biomarkers in breast cancer.Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients.Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring.Plasma HER2 amplification in cell-free DNA during neoadjuvant chemotherapy in breast cancer.Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker.The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis.
P2860
Q26772077-CDDCC997-5010-40B8-A185-0E09C866439FQ26785343-FF461B09-FB7B-41B6-B08B-10FA8CB28A72Q33778433-84305855-D3F7-440C-AC72-B1B2E56A86A1Q36234021-10B36845-85F0-441E-92CB-F15AF93024A8Q37242412-B43053E8-0B56-4D75-92CE-2C5082B5BD15Q37639092-0B22A2FF-DE3F-4DB5-804B-DDFE11C154B4Q37690204-825E2DE3-AD93-4693-BFDC-D50BA9844DA0Q38152782-AC231401-2F47-4D3A-821C-25F07D4FBFD7Q40261157-51F6FD61-4AA2-4701-BD9F-6A15A504ACC0Q42687570-82A949AD-3015-4F15-B01D-92BDB0FE74CCQ45795491-4136CEF2-BA2E-4988-B952-7BB6ECED9FF2Q46670174-D98830A4-280C-4581-B66B-B93D8000C4DEQ52622918-39575A19-391B-436B-965F-B24937E8F339
P2860
Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Methylated DNA and total DNA i ...... is for breast cancer patients.
@en
Methylated DNA and total DNA i ...... is for breast cancer patients.
@nl
type
label
Methylated DNA and total DNA i ...... is for breast cancer patients.
@en
Methylated DNA and total DNA i ...... is for breast cancer patients.
@nl
prefLabel
Methylated DNA and total DNA i ...... is for breast cancer patients.
@en
Methylated DNA and total DNA i ...... is for breast cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Methylated DNA and total DNA i ...... is for breast cancer patients.
@en
P2093
Atsushi Shimomura
Kenzo Shimazu
Koji Morimoto
Naomi Maruyama
Noriaki Yamamoto
Noriko Fujita
Seung Jin Kim
Shinzaburo Noguchi
Takahiro Nakayama
Yasuhiro Tamaki
P2860
P304
P356
10.1159/000342083
P577
2012-09-05T00:00:00Z